KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Change in Receivables (2016 - 2026)

Pacific Biosciences Of California has reported Change in Receivables over the past 16 years, most recently at $4.8 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 359.92% year-over-year to $4.8 million; the TTM value through Dec 2025 reached $7.9 million, up 187.16%, while the annual FY2025 figure was $7.9 million, 187.16% up from the prior year.
  • Change in Receivables for Q4 2025 was $4.8 million at Pacific Biosciences Of California, up from -$1.6 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $10.8 million in Q1 2023 and troughed at -$6.3 million in Q1 2024.
  • A 5-year average of $768473.7 and a median of $295000.0 in 2021 define the central range for Change in Receivables.
  • Biggest five-year swings in Change in Receivables: crashed 1445.76% in 2022 and later surged 359.92% in 2025.
  • Year by year, Change in Receivables stood at $295000.0 in 2021, then crashed by 1445.76% to -$4.0 million in 2022, then skyrocketed by 254.38% to $6.1 million in 2023, then plummeted by 130.33% to -$1.9 million in 2024, then soared by 359.92% to $4.8 million in 2025.
  • Business Quant data shows Change in Receivables for PACB at $4.8 million in Q4 2025, -$1.6 million in Q3 2025, and $612000.0 in Q2 2025.